Cargando…
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Damage or loss of brain cells and impaired neurochemistry, neurogenesis, and synaptic and nonsynaptic plasticity of the brain lead to dementia in neurodegenerative diseases, such as Alzheimer’s disease (AD). Injury to synapses and neurons and accumulation of extracellular amyloid plaques and intrace...
Autor principal: | Fišar, Zdeněk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687482/ https://www.ncbi.nlm.nih.gov/pubmed/36421690 http://dx.doi.org/10.3390/biom12111676 |
Ejemplares similares
-
Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
por: Ľupták, Matej, et al.
Publicado: (2021) -
Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer's Disease
por: Hroudová, Jana, et al.
Publicado: (2014) -
Interacting Models of Amyloid-β and Tau Proteins: An Approach to Identify Drug Targets in Alzheimer’s Disease
por: Priya, Khadgawat, et al.
Publicado: (2021) -
Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses
por: Kawahara, Masahiro, et al.
Publicado: (2011) -
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
por: Lue, Lih-Fen, et al.
Publicado: (2017)